CD79B and primary central nervous system lymphoma: Recurrent mutations in the JAK–STAT, NF-κB, and B-cell receptor (BCR) pathways, including CD79B, MYD88, and CDKN2A deletions, have been identified as the defining characteristics of primary central nervous system lymphomas (15–17).